Deepening presence in Australia with total investment and trade volume in Australia exceeding RMB 3 billion till date
Yili’s collaboration with Australia, initiated in 2016, has leveraged the country’s premium raw material resources and wellestablished industrial system to expand partnerships across various sectors. These include raw material sourcing, dairy farming, dairy technology R&D, and nutritional health products. With a total investment and trade volume exceeding RMB 3 billion, Yili has fostered mutually beneficial development in the China-Australia supply chain and industrial cooperation.
Recently, the 8th AustraliaChina CEO Roundtable Meeting took place in Beijing, where Liu Chunxi, Senior Executive President of Yili Group, participated and delivered a speech. Liu highlighted that Australia is rich in highquality agricultural and pastoral resources, with extensive expertise in dairy cattle breeding, pasture management, and dairy product R&D and manufacturing. He also noted that China offers a stable and positive macroeconomic environment, a thriving health food consumption market, and leadership in digitalization and low-carbon technology applications. According to Liu, the industries of the two countries are highly complementary, presenting broad prospects for cooperation.
In 2024, the ADP factory of Ausnutria, Yili’s subsidiary in Australia, obtained a formula registration certificate, becoming the first Australian company granted approval for the full range of infant formula products. This milestone marks a significant breakthrough for Yili’s operations in Australia and is expected to greatly enhance the global competitiveness of its infant formula offerings, offering superior quality assurance for maternal and infant health.
Yili’s Australian subsidiary, Nutrition Care, is a professional, pharmacy-grade nutrition brand. Its flagship product, NC Gastrointestinal Powder, has maintained the top position in China’s adult gastrointestinal healthcare compound powder market for several consecutive years. Recently, its probiotic product, NC Seasonal Biotic, also achieved top-selling status among Australian probiotic brands for nasal health.
In New Zealand, Yili’s business has been steadily progressing. Over a decade of investment and development has allowed the company to establish a presence across the entire value chain, including dairy sourcing, R&D, manufacturing, and brand marketing. Yili operates six production facilities and offers a range of products such as liquid milk, milk powder, butter, cheese, cream, yogurt, lactoferrin, and bovine colostrum. The company has partnerships with over 400 local farms, making it the largest Chinese dairy investor in New Zealand in terms of both scale and scope of cooperation. This setup enhances Yili’s role in the global supply chain and supports the dairy industry in the Australia-New Zealand region, creating a trans-Pacific dairy corridor.
Yili remains committed to an open and collaborative approach, aiming to expand its global market presence through technological innovation and global resource integration, with the goal of providing consumers worldwide with high-quality health food and promoting sustainable industry development.
